Sign up for free insights newsletter
BC

Bachem Holding AG

BCHMYUnited States

Need professional-grade analysis? Visit stockanalysis.com

$7.85
+1.95%
End of day
Market Cap

$5.78B

P/E Ratio

33.52

Employees

2,292

Dividend Yield

1.34%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.21-2.21
Calmar-18.18-18.18
Sharpe-6.98-6.98
Omega0.000.00
Martin-29.34-29.34
Ulcer3.193.19

Bachem Holding AG (BCHMY) Price Performance

Bachem Holding AG (BCHMY) trades on United States in USD. The company is classified in the Basic Materials sector under the Chemicals industry. The stock currently trades at $7.85, up 1.95% from the previous close.

Over the past year, BCHMY has traded between a low of $5.13 and a high of $9.36. The stock has gained 30.0% over this period. It is currently 16.1% below its 52-week high.

Bachem Holding AG has a market capitalization of $5.78B, with a price-to-earnings ratio of 33.52 and a dividend yield of 1.34%.

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Company Info

Industry
Chemicals
Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$677.93M
EBITDA
$199.73M
Profit Margin
19.79%
EPS (TTM)
0.23
Book Value
22.87

Technical Indicators

52 Week High
$9.40
52 Week Low
$5.13
50 Day MA
$7.57
200 Day MA
$7.41
Beta
0.98

Valuation

Trailing P/E
33.52
Forward P/E
24.63
Price/Sales
8.53
Price/Book
3.32
Enterprise Value
$5.64B